- Germany speeds up access to advanced therapies
- China’s draft patent linkage system
- Australia reclassified active medical device for therapy
- NICE encourages patients to have bigger input in choice of care
At the start of 2026, we identified five key pharmaceutical pricing and market access trends expecte...
Read moreGermany’s draft GKV Contribution Rate Stabilisation Act signals a clearly tighter environment ...
Read moreBe the first to receive exclusive content on the latest from the pharmaceutical and market access sector.
Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.
Get in touch